FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/03/041453 [Registered on: 29/03/2022] Trial Registered Prospectively
Last Modified On: 27/03/2022
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   Surfactant are alveolar surface reducing agents,used in preterm baby having lower pool surfactant i.e. respiratory distress syndrome. Sedation and pain reducing drug administration during surfactant therapy by less invasive technique will be assessed in this trial. 
Scientific Title of Study   Fentanyl versus placebo before less invasive surfactant administration: A Randomized Control Trial 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Bijan Saha  
Designation  Associate professor 
Affiliation  Institute of PostGraduate Medical Education and Research and SSKM Hospital 
Address  Department of Neonatology Institute of PostGraduate Medical Education and Research and SSKM Hospital Kolkata700020 India

Kolkata
WEST BENGAL
700020
India 
Phone  09051389120  
Fax    
Email  bijansaha18@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Bijan Saha  
Designation  Associate professor 
Affiliation  Institute of PostGraduate Medical Education and Research and SSKM Hospital 
Address  Department of Neonatology Institute of PostGraduate Medical Education and Research and SSKM Hospital Kolkata700020 India


WEST BENGAL
700020
India 
Phone  09051389120  
Fax    
Email  bijansaha18@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Bijan Saha  
Designation  Associate professor 
Affiliation  Institute of PostGraduate Medical Education and Research and SSKM Hospital 
Address  Department of Neonatology Institute of PostGraduate Medical Education and Research and SSKM Hospital Kolkata700020 India


WEST BENGAL
700020
India 
Phone  09051389120  
Fax    
Email  bijansaha18@gmail.com  
 
Source of Monetary or Material Support  
IPGMER SSKM HOSPITAL SSKM Hospital Rd Bhowanipore Kolkata West Bengal 700020 
 
Primary Sponsor  
Name  IPGMER SSKM HOSPITAL  
Address  244 AJC Bose Road Kolkata 700020  
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Bijan Saha  evel III Neonatal Care Unit Department of Neonatology IPGMER SSKM HOSPITAL   Department of neonatology 2nd floor NICU 244 AJC Bose Road Kolkata 700020 Kolkata WEST BENGAL
Kolkata
WEST BENGAL 
09051389120

bijansaha18@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IPGME & R Research Oversight Comitte  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: P220||Respiratory distress syndrome of newborn,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Fentanyl administration during Less Invasive Surfactant Administration   Patients having RDS who required FiO2 more than 30 % on Noninvasive positive pressure ventilation to maintain SpO2 90-95% in first 6 hours of life will be randomised to receive surfactant by LISA technique either by sedation with fentanyl or not . Intravenous fentanyl (1 mcg/kg over 2 minute) will be used for sedation during the LISA procedure and will be given before the procedure . 
Comparator Agent  nil  nil 
 
Inclusion Criteria  
Age From  1.00 Day(s)
Age To  2.00 Day(s)
Gender  Both 
Details  Preterm baby with gestational age between 28 to 34 weeks diagnosed with RDS will enroll in this study . RDS will be diagnosed clinically initially and later confirm by chest X ray .
A written informed consent will be obtained from the parents of the baby for participation in the study 
 
ExclusionCriteria 
Details  Baby with major congenital anomaly .
Perinatal asphyxia (cord blood pH<7.2).
Intubated at delivery room.
Alternative cause of respiratory distress.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant, Investigator and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
The primary outcome is the need for mechanical ventilation from the LISA procedure onwards up to 72 h of life.  The primary outcome is the need for mechanical ventilation from the LISA procedure onwards up to 72 h of life. 
 
Secondary Outcome  
Outcome  TimePoints 
Number of laryngoscopy attempts during the procedure
Complications occurring during and after the procedure SpO2 80 percentage hypotension with mean below gestational age bradycardia 100 bpm
Incidence of hsPDA
IVH above grade3
Broncho Pulmonary Dysplasia
Retinopathy of Prematurity requiring treatment
Culture positive sepsis
Necrotizing Enterocolitis above stage 3
Rate of feed intolerance
Gastrointestinal perforation confirmed on roentgenogram or surgical exploration
 
3month 
 
Target Sample Size   Total Sample Size="320"
Sample Size from India="320" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   31/03/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="3"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   For all nonemergent neonatal ventilation,premedicarion is considered mandatory.Awake laryngoscopy is known to be painful and associated with many adverse events.There is still no concensus on whether or not to use sedation during LISA.  With sedation LISA procedure become smooth and sucessful but it might compromise the infants respiratory drive which is a prerequisite for LISA. This study will therefore be conducted to determine the efeects of fentanyl on the requirement of mechanical ventilation in the 72hr following the procedure in infants with RDS. 
Close